1. Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature

   • Thomas M. Caparrotta
   • Daniel J. Antoine
   • James W. Dear

   Review Open access 24 October 2017 Pages: 147 - 160

   

2. Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases

   • Fredrik N. Albach
   • Frank Wagner
   • Jürgen Steffgen

   Clinical Trial Open access 10 November 2017 Pages: 161 - 169

   

3. Drug safety in pregnancy: the German Embryotox institute

   • Katarina Dathe
   • Christof Schaefer

   Special Article 24 October 2017 Pages: 171 - 179

   

4. Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report

   • Xia Yang
   • Wei Liu
   • Kai Hu

   Special Article 27 October 2017 Pages: 181 - 182

5. Risk factors for QTc interval prolongation

   • Charlotte P. M. Heemskerk
   • Marieke Pereboom
   • Matthijs L. Becker

   Pharmacodynamics 22 November 2017 Pages: 183 - 191

   

6. Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study

   • Andrea V. Margulis
   • Jesper Hallas
   • Alejandro Arana

   Pharmacoepidemiology and Prescription 13 November 2017 Pages: 193 - 199

7. Antidepressants and suicidal behaviour in late life: a prospective population-based study of use patterns in new users aged 75 and above

   • Khedidja Hedna
   • Karolina Andersson Sundell
   • Margda Waern

   Pharmacoepidemiology and Prescription Open access 04 November 2017 Pages: 201 - 208

8. Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden

   • Pernilla J. Bjerkeli
   • Shai Mulinari
   • Juan Merlo

   Pharmacoepidemiology and Prescription Open access 03 November 2017 Pages: 209 - 218

   

9. Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

   • Irene Eriksson
   • Thomas Cars
   • Mia von Euler

   Pharmacoepidemiology and Prescription Open access 11 November 2017 Pages: 219 - 226

   

10. The use of an electronic clinical rule to discontinue chronically used benzodiazepines and related Z drugs

    • C. Mestres Gonzalvo
    • V. Milosevic
    • P. H. M. van der Kuy

    Pharmacoepidemiology and Prescription 10 November 2017 Pages: 227 - 231

    

11. Can clinical practice indicator relating to long-acting benzodiazepine use in the elderly be easily generated in a hospital setting?

    • Badria Kadri
    • Antonio Teixeira
    • Pénélope Troude

    Pharmacoepidemiology and Prescription 16 November 2017 Pages: 233 - 241

    

12. Perampanel-associated self-harm ideation after dosage increase

    • Farid Kheloufi
    • Anne Default
    • Joëlle Micallef

    Letter to the Editor 11 November 2017 Pages: 243 - 244

13. Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer

    • A. Garrahy
    • A. M. Hannon
    • C. J. Thompson

    Letter to the Editor 16 November 2017 Pages: 245 - 246

14. Medication errors with tramadol drops in children

    • Florence Moulis
    • Geneviève Durrieu
    • Jean-Louis Montastruc

    Letter to the Editor 06 November 2017 Pages: 247 - 248

15. Journals’ TOP guidelines transparency level should be disclosed

    • Rafael Dal-Ré

    Letter to the Editor 09 November 2017 Pages: 249 - 250

16. In response to: “Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning”

    • Elie Harmouche
    • Mary Ann Howland
    • Mark K Su

    Letter to the Editor 20 November 2017 Pages: 251 - 251

17. In reply

    • Anselm Wong
    • Cornelia B. Landersdorfer
    • Andis Graudins

    Letter to the Editor 16 November 2017 Pages: 253 - 253

18. Correction to: Metoclopramide role in preventing ileus after cesarean, a clinical trial

    • Jila Agah
    • Roya Baghani
    • Abolfazl Rad

    Correction 16 November 2017 Pages: 255 - 255